icone plus
Contact Abonnez-vous aux actualités
Reason for request
Modification du RCP
Modification d’AMM du 02/07/2018 : restriction de l’indication aux patients ayant une tumeur avec expression de PD-L1 ≥ 5% dans le traitement du carcinome urothélial chez les patients inéligibles au cisplatine
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
RREGBgZQVUbYVhS0
Listen
